Biotech Values

[dewophile]

when i say lambda appears more potent i am purely stating that based on VL reduction - no commentary as to MOA

PS: i just got around to looking at the posters. they have a second poster modeling kinetics based on data from weekly dosing cohorts through week 4 to predict cEVR (a 12 week endpoint). per the model (which admittedly may be off given it"s based on only 22 patient data) .66ug lamda should yeild comparable efficacy to 1.5 of alpha